Archive for April, 2012

Yorks. innovation centre offers potential for scientific sales jobs

Friday, April 27th, 2012

A new North Yorkshire innovation centre is expected to create hundreds of scientific jobs, including scientific sales jobs.

The Sand Hutton Applied Innovation Campus is to welcome its first tenants later this year, providing start-up and developing scientific businesses with the investment and research facilities to help them grow.

The site includes the York Science and Enterprise Centre, which was part funded by the European Regional Development Fund (ERDF).

The campus spokesman, Dr Patrick Bonnett, said that the labs and research amenities on the site would operate on a ‘plug and play’ principle, in that they could be changed to meet the needs of all the different companies as they develop.

He told the Yorkshire Post that it would become a “multi-occupancy site populated by a range of knowledge rich science and innovation based organisations”.

“Businesses are focused on the areas of food, environment and applied life sciences with the common theme being ‘translational’ research,” Dr Bonnett explained. “They are working across scientific disciplines to deliver practical applications that help people and society.”

As well as the labs and offices the site also offers a 250-seat conference hall, along with meeting rooms and a video conferencing facility.

Medical sales provide Philips with first quarter turnaround

Tuesday, April 24th, 2012

The medical sales division of Dutch electronics giant, Philips Electronics, has helped the company stage a strong economic turnaround in the first quarter of 2012.

The company made a loss of €160 million in the fourth quarter of 2011, but has reported that it made a first-quarter net profit of €249 million in 2012, after sales climbed to some €5.608 billion.

The company’s chief executive, Frans van Houten, said that Philips’ healthcare products have significantly increased their market share, showing that the company is “beating the competition”, even in a tough economic environment. He warned, however, that cut backs in government spending on healthcare across Europe meant that they remained cautious for the rest of 2012.

“We remain cautious about the remainder of 2012 given the uncertainties in Europe, particularly in the healthcare and construction markets, and the slowing growth rate in the global economy,” he explained.

The healthcare division of Philips produces a wide range of medical equipment used in hospitals, surgeries and domestic settings throughout Europe, ranging from home oxygen kits to hospital scanners.

Mr van Houten said that further restructuring of the company would be taking place in 2012, with particular focus put on the company’s corporate culture – which many people within the company consider overly consensus-driven and cautious.

Medical sales jobs contribute to Omega success

Tuesday, April 17th, 2012

People in medical and scientific sales jobs at medical testing kit maker, Omega Diagnostics, have contributed to an expected 40 per cent rise in the company’s full-year sales.

The company has benefited significantly from buying out German lab testing firm Allergopharma in November 2010, with Germany now Omega’s largest market.

In its pre-close trading update, the company, which is based in Alva in Scotland, has forecast that is revenues for the year to 31 March will be £11.1 million – up from £7.9 million for the previous 12 months.

Omega’s chief executive, Andrew Shepherd, said that underlying sales showed a year-on-year rise of 5 per cent.

“We are very pleased with the progress Omega has made and the overall business is performing strongly,” Shepherd said.

“We are also looking forward to significant opportunities presented by direct access into the Indian market, the launch of a range of allergy tests onto the automated IDS-iSYS platform and new prospects that exist that could transform the performance within our infectious disease portfolio.”

The revenue generated by Allergopharma is expected to have increased by more than 300 per cent on the previous year at £3.87 million, while sales of Omega’s food intolerance testing kits are expected to have risen by 10 per cent to approximately £3.9 million.

Sony turnaround plan could create medical sales jobs

Friday, April 13th, 2012

Global electronics giant Sony is looking to revive its ailing fortunes through the mobile electronics and medical equipment sectors, paving the way for new medical sales jobs.

The Japanese company this week announced that it was doubling the size of its estimated annual loss forecast to a record $6.4 billion, having lost major ground in its previously dominant television sector to companies including Apple and Samsung.

The company’s chief executive, Kazuo Hirai, told a packed news conference in Tokyo this week that the firm would be heeding “a multitude of investor voices calling for change” and that it would continue to enhance its long-held ethos of being an entrepreneurial company.

The company has been eyeing growth in the medical equipment market – particularly endoscopes. Sony has been linked as a potential partner to Olympus, which has a 70 per cent share of the global endoscope market, but needs to shore up its finances following a $1.7 billion accounting fraud.

Mr Hirai said that Sony is looking to establish total group sales of around $105 billion in 2014/15, with an operating margin of at least 5 per cent. He said that medical equipment sales would prove crucial to this.

NHS developing new procurement framework

Tuesday, April 10th, 2012

The NHS is restructuring the roles of its medical and hospital sales jobs as part of a new framework for the supply and maintenance of NHS IT hardware and services.

The framework – which has an estimated value of between £45 million and £125 million – is being established by the NHS Commercial Procurement Collaborative and NHS Shared Business Services.

A notice on the new initiative, issued by the Official Journal of the European Union, stated that the deal will cover the delivery of desktop computers and peripherals, laptops and touchscreen monitors, as well as medical equipment including x-ray workstations, mobile clinical assistant devices for use in “point of care and mobile environments”.

A wide range of some of the UK’s most eminent NHS trusts in England are expected to make use of the framework, including Alder Hey children’s, Liverpool primary care, South West Yorkshire partnership and Yorkshire ambulance service.

The NHS Commercial Procurement Collaborative is the national procurement service for many public medical services across England. It sill set up the framework for an initial two-year period, but there will be the option to extend it for two further two-year terms.

Panasonic medical sale rebranding promises future opportunities

Tuesday, April 3rd, 2012

Panasonic has announced that it has rebranded its European medical and scientific device operation as Panasonic Biomedical Sales Europe BV (PHCBEU), in order enhance sales of medical equipment throughout the continent.

The division was previously known as SANYO E&E Europe BV, but the rebranding follows Panasonic’s full acquisition of SANYO in 2011 and the creation of Panasonic Healthcare Company Europe (PHCEU) in January 2012.

Deputy Managing Director of PHCBEU, Hans Brok, said that the newly-created brand will reflect Panasonic’s expanded and still-growing healthcare operation. It will continue to offer the broad range of biomedical products available previously, including ultra-low temperature freezers, incubators, medical refrigerators and cell processing systems.

“By integrating the businesses and facilitating shared expertise we are even better positioned to offer our existing and prospective customers a bigger and better product range,” Brok explained. “In addition, we are confident that we have a stronger foundation for future business growth in Europe, in the medical industry.”

Panasonic has stated that they will continue to offer product support to former customers of SANYO, whether they are within or outside their warranty periods. Brok added that these customers will now also benefit from a broader range of available technology.